Home Health & Hospice M&A

Own one? Selling a home health or hospice agency: what it's worth, who buys and the steps to sell.

Valuation snapshot

Hospice valuation: what a home health or hospice business is worth in 2026

Owner-operated home health and hospice agencies sell for a median 3.3x-3.4x SDE (seller's discretionary earnings) across size bands in Axia Growth's Healthcare sector data, a sector proxy updated October 28, 2026.

Multiples by size, with the source and date of each figure
SizeMultipleSource and date
Under $500K of SDE (owner-operated)3.4x SDE middle half 2.7x-4.2xAxia Growth sector data, Healthcare sector (proxy), 182 sales, updated October 28, 2026
$500K-$1M of SDE (owner-operated)3.4x SDE middle half 2.5x-4.4xAxia Growth sector data, Healthcare sector (proxy), 42 sales, updated October 28, 2026
$1M-$2M of SDE (owner-operated)3.3x SDE middle half 2.7x-7.5xAxia Growth sector data, Healthcare sector (proxy), 22 sales, updated October 28, 2026

The SDE rows are a sector proxy: Axia Growth publishes multiples for the Healthcare sector, not for home health and hospice agencies alone.

Source for the SDE rows: Axia Growth analysis of 4,554 closed small-business sales over $500K, aggregated and de-identified. Methodology.

What moves a home health and hospice multiple

  • Survey and compliance history. Clean Medicare surveys, no open audits and a hospice cap position that does not create a repayment risk.
  • Payer mix. The balance of Medicare, Medicare Advantage, Medicaid and private pay, and exposure to rate changes.
  • Referral sources. Many referral relationships with hospitals and physicians, rather than a few that could leave.
  • Licensing and enrollment. How the Medicare enrollment moratorium and certificate-of-need rules affect transferring the agency's provider number.
  • Clinical staff. Nurses and clinical managers who stay after the sale, in a tight labor market.

What increases a business’s valuation →

Get a free home health and hospice valuation→ Get your detailed valuation, based on real business sales. Free and confidential.

Last updated

In short

What is a home health or hospice agency worth?

In Axia Growth's analysis of closed small-business sales, home health and hospice agencies are grouped in the Healthcare sector, where businesses with under $500K of SDE sold for a median 3.4x SDE (middle half 2.7x-4.2x) across 182 sales, updated October 28, 2026. According to Mertz Taggart, Kinderhook Industries took Enhabit private at a 10.2x EBITDA multiple, roughly $1.1 billion enterprise value on $108 million of EBITDA. The two figures use different bases: Axia Growth's figure is a multiple of SDE from owner-operated small-business sales, while the Mertz Taggart figure is a multiple of EBITDA from larger, often private-equity-backed deals, so the higher number is expected, not a contradiction.

Home-based care M&A slowed by count but not by dollars in 2026: Mertz Taggart tracked 16 closed transactions in Q2 2026, down from 27 in Q1, while Kinderhook took Enhabit private at roughly $1.1 billion. Reimbursement is mixed, with a 2.3% FY 2027 hospice payment update against a 1.3% aggregate home health cut for CY 2026. A nationwide CMS enrollment moratorium that began May 13, 2026 now shapes how deals are structured.

Why published multiples differ

Published multiples differ mostly because they use different earnings and deal sizes. Small, owner-run businesses (under $2M of earnings) are priced on SDE, seller's discretionary earnings, which adds back the owner's pay, so SDE multiples are lower. From $2M of earnings up, buyers price on EBITDA, and multiples rise with size. Averages that mix sizes, or quote larger private-equity deals, read higher than a small-business sale.

Multiples by deal size

Sector: Healthcare. Median and middle half (p25-p75) of sale price to earnings.

Closed small-business sales in the Healthcare sector, by deal size. Axia Growth analysis of closed small-business sales, updated October 28, 2026.
Size bandnMedian multiplep25-p75Basis
Under $500K SDE1823.4x2.7x-4.2xSDE
$500K-$1M SDE423.4x2.5x-4.4xSDE
$1M-$2M SDE223.3x2.7x-7.5xSDE
$2M-$3M EBITDA135.1x3.1x-10.9xEBITDA
$5M-$10M EBITDA148.8x3.4x-10.7xEBITDA
$10M+ EBITDA1712.9x9.4x-18.5xEBITDA

Source: Axia Growth analysis of 4,554 closed small-business sales over $500K, aggregated and de-identified. Data as of 2026-10-28. Methodology.

No published cell for the Healthcare size band: $3M-$5M EBITDA. Each has fewer than 10 closed sales, so Axia Growth does not estimate a multiple for it.

How much is a hospice or home health agency worth?

Hospice and home health agencies sell for a multiple of earnings. In Axia Growth's Healthcare sector data, businesses with under $500K of SDE sold for a median 3.4x SDE, with the middle half between 2.7x and 4.2x, across 182 closed sales. With $500K-$1M of SDE, the median was 3.4x SDE (42 sales).

Source: Axia Growth analysis of 4,554 closed small-business sales over $500K, aggregated and de-identified. Data as of October 28, 2026.

  • 16[1]

    Closed home-based care transactions, Q2 2026

    Down from 27 in Q1 2026 and 29 in Q2 2025; hospice and home care 8 each, skilled home health 6

  • 10.2x[1]

    Enhabit take-private EBITDA multiple

    Kinderhook Industries, roughly $1.1 billion enterprise value on $108 million of EBITDA

  • 2.3%[5]

    FY 2027 hospice payment update

    FY 2027 hospice cap set at $36,174.75

  • 21.2%[6]

    Freestanding HHA FFS Medicare margin, 2024

    MedPAC; it recommended a 7% cut to the 2026 base rate for CY 2027

  • -1.3%[3]

    CY 2026 aggregate home health payment change

    About $220 million; the CY 2027 proposed rule would raise payments 2.4%

M&A activity snapshot

Deal count in home-based care fell in the second quarter of 2026, but deal size did not. Mertz Taggart tracked 16 closed home-based care transactions in Q2 2026, down from 27 in Q1 2026 and 29 in Q2 2025. Hospice and home care tied at 8 closed deals each, and skilled home health closed 6.

Two Q2 closings rank among the largest in the sector's history. General Atlantic acquired TEAM Services Group from Alpine Investors for a reported ~$3 billion. Kinderhook Industries took Enhabit private at roughly $1.1 billion enterprise value. New platform formation (6 deals) outpaced sponsor-backed add-ons (4), a reversal of recent years.

The sector is large and still fragmented. In 2024, about 2.7 million Medicare FFS beneficiaries received home health care, and Medicare spent $16.0 billion on it. That year, over 12,000 HHAs were certified to participate in Medicare. It also notes that investor interest in home health care services has slowed since 2023, after a peak period for agency M&A.

Who is buying

The biggest recent strategic move came from a payer-owned operator. UnitedHealth's $3.3 billion merger with Amedisys cleared the Justice Department only after a settlement. It required the companies to divest 164 home health and hospice locations across 19 states, roughly $528 million in annual revenue.

Public post-acute companies picked up those assets. Under the settlement, BrightSpring will acquire 115 divested sites, while Pennant will acquire 49. Other public strategics are buying in adjacent home-based segments. Addus HomeCare acquired HomeCourt Home Care, marking its entry into Indiana. Aveanna Healthcare agreed to acquire Family First Homecare for $175.5 million, a pediatric private-duty nursing provider.

Private equity is the steady source of hospice add-ons. In Q2 2026, Webster Equity Partners-backed Bristol Hospice acquired Hope Hospice & Palliative Care, and Norwest made a platform investment in Ennoble Care. Health systems are also selling. Deacon Associates agreed to acquire 31 home health and hospice agencies from HCA Healthcare, a deal not yet closed at quarter-end.

What buyers look for

Buyers are paying for clean operations more than for growth. Mertz Taggart lists the profile that still earns premium pricing: strong financials, clean compliance histories, strong management teams, established referral networks, stable census, and a favorable payer mix. The core diligence metrics follow from that list: census and average daily census, referral-source concentration, Medicare versus Medicare Advantage mix, and survey history.

Enrollment history is now a gating item. Under the 36-month rule, an agency acquired, changed ownership, or was initially enrolled within the prior 36 months may face restrictions on a later change of ownership. Buyers check this before they price anything.

Geography matters for hospice in particular. CMS has imposed heightened screening on hospices newly enrolling or changing ownership in Arizona, California, Georgia, Nevada, Ohio, and Texas. Targets in those states face longer diligence and more structuring questions.

Hospice buyers also model cap exposure. Medicare applies a statutory aggregate cap to the payments each hospice receives annually, and the FY 2027 cap is $36,174.75. A hospice with long average lengths of stay can owe repayments, so buyers review cap liability by year.

What raises the multiple

A home health or hospice agency that reaches the top of the buyer range typically shows:

  • A Medicare enrollment history outside the 36-month window, with no pending change-of-ownership issues.
  • Stable or rising census fed by several referral sources, not a single hospital or physician group.
  • Clean state surveys and accreditation, and no open program-integrity reviews.
  • For hospice, a documented history of staying under the aggregate cap, with no recent repayment demands.
  • A licensed footprint in certificate-of-need states, where CON approval is often tied to state licensure and limits new competitors.
  • Management and clinical leadership that can run the agency without the founder.

Medicare economics remain favorable for efficient operators. FFS Medicare margins for freestanding HHAs averaged 21.2 percent in 2024. For hospice, the aggregate FFS Medicare margin for 2023 was 8.0 percent, down from 9.8 percent in 2022. These are fee-for-service averages and do not reflect Medicare Advantage or Medicaid business.

Valuation and deal structure

Reliable multiple data for small agencies is not publicly available. The clearest 2026 marker is the Enhabit deal: a 10.2x EBITDA multiple on $108 million of EBITDA, a 24% premium to the undisturbed share price. That is a large public-company deal. Smaller private deals generally price below larger private-equity deals, and small-agency sale data varies widely.

Reimbursement shapes what a buyer will pay. CMS cut CY 2026 home health payments in the aggregate by an estimated 1.3%, or $220 million, including a permanent prospective adjustment of -1.023% tied to PDGM behavior assumptions. The CY 2027 proposed rule would increase payments in the aggregate by 2.4%, or $420 million. It also keeps a temporary 3.0% reduction to the CY 2027 home health base payment rate.

Hospice payments are moving the other way. CMS finalized a 2.3% FY 2027 update, an estimated $755 million increase over FY 2026. MedPAC disagrees with both trends: it recommended Congress reduce the 2026 Medicare base payment rate for HHAs by 7 percent and eliminate the FY 2027 hospice update.

Structure now matters as much as price. On May 13, 2026, CMS imposed a six-month nationwide temporary moratorium on Medicare enrollment for new home health agencies and hospices. During that period, only change of information (COI)-eligible equity deals can preserve Medicare billing without interruption. Sellers should expect delayed closings and renegotiated terms if the moratorium is extended.

State review adds another layer. At least 14 states now require advance notice to the attorney general or a related agency before a private equity, hedge fund, or MSO-affiliated transaction closes. Earnouts and seller rollover are common in sponsor-backed healthcare deals generally, but none of the sources above break out their use for this segment.

Outlook

Expect transaction structure to drive the next 12 to 24 months. The moratorium is initially set to run through approximately November 13, 2026, subject to six-month extensions. While it lasts, agencies with long, clean enrollment histories hold scarce Medicare numbers that new entrants cannot replicate.

Hospice should keep drawing sponsor capital because of steady rate updates, while home health depends on whether CMS holds to the proposed CY 2027 increase. Fraud enforcement and state transaction-review laws will keep diligence long. Owners who clean up compliance and enrollment records before a process are best placed to hold value through closing.


Own a home health or hospice agency and want a starting point before you talk to buyers? Run the valuation tool or read the Healthcare Services M&A overview. See also: why vertical-specific buyers outperform generalists in outbound.

Other Healthcare Services subindustries

Frequently asked questions

What multiple do home health and hospice agencies sell for?

Owner-operated home health and hospice agencies sell for a median 3.3x-3.4x SDE (seller's discretionary earnings) across size bands in Axia Growth's Healthcare sector data, a sector proxy updated October 28, 2026. The SDE rows are a sector proxy: Axia Growth publishes multiples for the Healthcare sector, not for home health and hospice agencies alone. Source: Axia Growth analysis of 4,554 closed small-business sales over $500K, aggregated and de-identified. Axia Growth groups home health and hospice agencies in the Healthcare sector, the closest published proxy: businesses with under $500K of SDE sold for a median 3.4x SDE across 182 sales (Axia Growth analysis of closed small-business sales, updated October 28, 2026).

What is a home health or hospice agency worth?

In Axia Growth's analysis of closed small-business sales, home health and hospice agencies are grouped in the Healthcare sector, where businesses with under $500K of SDE sold for a median 3.4x SDE (middle half 2.7x-4.2x) across 182 sales, updated October 28, 2026. According to Mertz Taggart, Kinderhook Industries took Enhabit private at a 10.2x EBITDA multiple, roughly $1.1 billion enterprise value on $108 million of EBITDA. The two figures use different bases: Axia Growth's figure is a multiple of SDE from owner-operated small-business sales, while the Mertz Taggart figure is a multiple of EBITDA from larger, often private-equity-backed deals, so the higher number is expected, not a contradiction.

SDE or EBITDA: which applies to my home health or hospice agency?

Axia Growth reports multiples of SDE (seller's discretionary earnings) for businesses with under $2M of earnings, where owner-operated businesses are usually priced, and multiples of EBITDA from $2M up, matching how buyers and brokers talk about deal size. For the Healthcare sector, Axia Growth publishes both SDE and EBITDA bands.

How does the 2026 CMS enrollment moratorium affect a sale?

CMS imposed a six-month nationwide moratorium on new home health and hospice Medicare enrollments on May 13, 2026, initially running to about November 13, 2026. Any deal that requires a new enrollment is effectively blocked, so buyers favor equity structures that keep the existing Medicare number. Source: Nixon Peabody.

What is the hospice 36-month rule?

An agency that was acquired, changed ownership, or was initially enrolled within the prior 36 months may face restrictions on a subsequent change of ownership. In some cases the buyer must re-enroll the agency entirely, which the current moratorium does not allow. Source: Mertz Taggart.

How do I get a value range for my business?

Enter your industry and annual earnings in the free business value calculator for a value range drawn from the same closed-sales data. The multiples by sector page shows every published size band.

Sources

  1. Q2 2026 Home-Based Care M&A Report — Mertz Taggart, 2026-07-21 (accessed 2026-10-03)
  2. Q1 2026 Home-Based Care M&A Report — Mertz Taggart, 2026 (accessed 2026-10-03)
  3. Calendar Year (CY) 2026 Home Health Prospective Payment System Final Rule (CMS-1828-F) — Centers for Medicare & Medicaid Services, 2025-11-28 (accessed 2026-10-03)
  4. Calendar Year (CY) 2027 Home Health Prospective Payment System Proposed Rule Fact Sheet (CMS-1844-P) — Centers for Medicare & Medicaid Services, 2026-07 (accessed 2026-10-03)
  5. Fiscal Year 2027 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Program Requirements Final Rule (CMS-1851-F) — Centers for Medicare & Medicaid Services, 2026-07-30 (accessed 2026-10-03)
  6. Report to the Congress: Medicare Payment Policy, March 2026 (Executive Summary) — Medicare Payment Advisory Commission (MedPAC), 2026-03 (accessed 2026-10-03)
  7. CMS hospice and home health agency moratorium: Impact on M&A and ownership changes — Nixon Peabody, 2026-05-14 (accessed 2026-10-03)
  8. Selling a Home Health, Hospice, or Home Care Agency in 2026 — Mertz Taggart, 2026 (accessed 2026-10-03)
  9. UnitedHealth and Amedisys reach settlement with DOJ over $3.3B merger — Healthcare Dive, 2025-08-07 (accessed 2026-10-03)
  10. Certificate of Need Programs for Home Health and Hospice — National Alliance for Care at Home, 2026 (accessed 2026-10-03)

Cite this guide

In Axia Growth's analysis of closed small-business sales, home health and hospice agencies are grouped in the Healthcare sector, where businesses with under $500K of SDE sold for a median 3.4x SDE (middle half 2.7x-4.2x) across 182 sales, updated October 28, 2026. According to Mertz Taggart, Kinderhook Industries took Enhabit private at a 10.2x EBITDA multiple, roughly $1.1 billion enterprise value on $108 million of EBITDA. The two figures use different bases: Axia Growth's figure is a multiple of SDE from owner-operated small-business sales, while the Mertz Taggart figure is a multiple of EBITDA from larger, often private-equity-backed deals, so the higher number is expected, not a contradiction. Home health and hospice M&A in 2026: 16 closed deals in Q2, a 2.3% FY 2027 hospice rate update, and a CMS enrollment moratorium reshaping deal structure.

When using information from this guide, cite Axia Growth and link to this page.

Axia Growth. Home Health & Hospice M&A. Updated 2026-11-05. https://axiagrowth.com/resources/industries/healthcare/home-health-hospice

For buyers

Have a mandate in Home Health & Hospice? Share your buy box.

Share your buy box

For owners

Own a business in Home Health & Hospice? Book a confidential call.

Book a confidential call

For buyers

See who's in your buy box.

Submit your criteria

For owners

Thinking about selling?

Tell us about your business